Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
As of mid-2026, Retatrutide has completed its first successful Phase 3 trial (TRIUMPH-1, reported May 2026), with seven further Phase 3 trials expected to report throughout 2026 covering different patient groups and outcomes
Work in Lausanne (BT) was supported by grants from the Swiss National Science Foundation and the European Research Council
Swallow the tablet whole
Persistent ED beyond 3 months If erectile function has not returned to baseline or improved after 3 months on stable-dose tirzepatide , something else is going on
Any efficacy claim about a steady 2.5 mg maintenance dose is extrapolation from that dose-response curve, not direct randomized-trial evidence at that specific maintenance level
Semaglutide, for example, can cause nausea or gastrointestinal discomfort, especially when a person first begins treatment
US$ 20.45
US$ 22.39
US$ 25.51
US$ 24.43
